ConductScience.org, home

Paper41300545

Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children.

Zaitoon H and 3 others. Children (Basel), 2025. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Papers, record 41300545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300545

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children.
PubMed
Journal
Children (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
3.12, provisional
iCite
Revised in PubMed
2025-11-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zaitoon HHusseinhttps://orcid.org/0000-0002-4979-3799
2Wauters ADAimee D
3Rodriguez LMLuisa M
4Lynch JLJane L

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References87

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132581001Flualprazolam: Report of an Outbreak of a New Psychoactive Substance in Adolescents.Pediatrics2020https://conductscience.org/library/papers/32581001PubMed
239065679Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39065679PubMed
335658022Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes.N Engl J Med2022https://conductscience.org/library/papers/35658022PubMed
432635439Is BMI a Valid Indicator of Overweight and Obesity for Adolescents?Int J Environ Res Public Health2020https://conductscience.org/library/papers/32635439PubMed
537366315Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.N Engl J Med2023https://conductscience.org/library/papers/37366315PubMed
640588554GLP-1 receptor agonists for the treatment of obesity in children and adolescents: a meta-analysis of randomized controlled trials.Pediatr Res2026https://conductscience.org/library/papers/40588554PubMed
725036533Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial.Diabetes Technol Ther2014https://conductscience.org/library/papers/25036533PubMed
833984333Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis.J Pediatr2021https://conductscience.org/library/papers/33984333PubMed
935900132Addressing adolescent substance use with a public health prevention framework: the case for harm reduction.Ann Med2022https://conductscience.org/library/papers/35900132PubMed
1039044306Glucagon-like peptide-1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity-a systematic review and network meta-analysis.Diabetes Obes Metab2024https://conductscience.org/library/papers/39044306PubMed
1140450457
Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society.
Am J Clin Nutr2025https://conductscience.org/library/papers/40450457PubMed
1232753461Obesity in adults: a clinical practice guideline.CMAJ2020https://conductscience.org/library/papers/32753461PubMed
1336398631Expanding the Role of Bioethics in Translational Science.J Law Med Ethics2022https://conductscience.org/library/papers/36398631PubMed
1436322838Once-Weekly Semaglutide in Adolescents with Obesity.N Engl J Med2022https://conductscience.org/library/papers/36322838PubMed
1538663923Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.BMJ Open2024https://conductscience.org/library/papers/38663923PubMed
1633963681Liraglutide pharmacokinetics and exposure-response in adolescents with obesity.Pediatr Obes2021https://conductscience.org/library/papers/33963681PubMed
1732062862A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity.Pediatr Obes2020https://conductscience.org/library/papers/32062862PubMed
1837213102Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.JAMA Netw Open2023https://conductscience.org/library/papers/37213102PubMed
1932471767Counterfeit drugs: A major issue for vulnerable citizens throughout the world and in the United States.J Am Pharm Assoc (2003)2021https://conductscience.org/library/papers/32471767PubMed
2040181228How do glucagon-like Peptide-1 receptor agonists affect measures of muscle mass in individuals with, and without, type 2 diabetes: A systematic review and meta-analysis.Obes Rev2025https://conductscience.org/library/papers/40181228PubMed

See all 87 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42733817Specialty-based variation in glucagon-like Peptide-1 receptor agonist prescribing practices for adolescent obesity in Saudi Arabia.Obes Pillars2026https://conductscience.org/library/papers/42733817PubMed
42625929Current and forthcoming pharmacotherapies for adolescent obesity: Evidence-based review.World J Clin Pediatr2026https://conductscience.org/library/papers/42625929PubMed
42514386Understanding Obesity as a Multisystem Disease: Advancing Research, Redefining Diagnostic Criteria, and Establishing Modern Therapeutic Approaches.Nutrients2026https://conductscience.org/library/papers/42514386PubMed
42464044Bridging the Gaps in Paediatric Obesity Pharmacotherapy.Diabetes Obes Metab2026https://conductscience.org/library/papers/42464044PubMed
42194134
Reply to Improda, N.; Ballarin, G. Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on "Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427".
Children (Basel)2026https://conductscience.org/library/papers/42194134PubMed
42194133Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427.Children (Basel)2026https://conductscience.org/library/papers/42194133PubMed
42117035Oral Nutritional Supplements and Body Composition Outcomes Among GLP-1 Receptor Agonist Users: Real-World Evidence.Diabetes Metab Syndr Obes2026https://conductscience.org/library/papers/42117035PubMed
41798193Glucagon-like peptide-1 agonists in children with obesity and type 2 diabetes. an umbrella review.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41798193PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41300545

GET https://conductscience.org/api/papers/v1/41300545/references?page=2